Inventor

QIU HUAWEI

US45 patents

⚠️ This page may combine multiple inventors who share the name “QIU HUAWEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

QIU HUAWEI

GENZYME CORP

Fc containing polypeptides with altered glycosylation and reduced effector function

Hyperglycosylated binding polypeptides

Site-specific antibody-drug conjugation through glycoengineering

Hyperglycosylated binding polypeptides

Site-specific antibody-drug conjugation through glycoengineering

Fc containing polypeptides with altered glycosylation and reduced effector function

Hyperglycosylated binding polypeptides

scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidity and specificity

Site-specific antibody-drug conjugation through glycoengineering

Site-specific glycoengineering of targeting moieties

ScFv-Fc dimers that bind transforming growth factor-BETA1 with high affinity, avidity and specificity

Anti-αβTCR antibody

Nucleotide sequences encoding VEGF antagonist compositions of FLT-1 and uses thereof

Modified human acid sphingomyelinase having increased activity, and methods for making the same

Site-specific antibody-drug conjugation through glycoengineering

scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidity and specificity

Bone-targeting antibodies

Modified-IgG antibodies that bind transforming growth factor-β1 with high affinity, avidity and specificity

Modified-IgG antibodies that bind transforming growth factor-BETA1 with high affinity, avidity and specificity

Modified-IgG antibodies that bind transforming growth factor-β1 with high affinity, avidity and specificity

Anti-CD52 antibodies

Fc containing polypeptides with altered glycosylation and reduced effector function

Anti-alpha beta TCR binding polypeptides with reduced fragmentation

scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidity and specificity

Bone-targeting antibodies

Site-specific glycoengineering of targeting moieties

Modified binding polypeptides for optimized drug conjugation

FGFR3 antibodies and methods of use

Engineered anti-TGF-β antibodies and antigen-binding fragments

Engineered anti-TGF-beta antibodies and antigen-binding fragments

SANOFI SA

Anti-TGF-beta antibodies and their use

Anti-TGF-β antibodies and their use

Trispecific binding proteins, methods, and uses thereof

Trispecific binding proteins, methods, and uses thereof

Anti-TGF-beta antibodies and their use

Anti-CHIKV antibodies and uses thereof

Anti-CHIKV monoclonal antibodies directed against the E2 structural protein

XILIO DEV INC

Masked cytokine polypeptides

Masked IL-2-Fc fusion polypeptides

Masked interleukin-12 polypeptides

Masked cytokine polypeptides

Masked cytokine polypeptides

Tumor-specific cleavable linkers

STEFANO JAMES

VEGF antagonist compositions and uses thereof

SNELL DANIEL

Anti-αβTCR antibody